3 unknown. 3 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 3 | Unknown 3 |
Follow Vasculitis: new trials by email Literature Review of Vasculitis trials Research Report on Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study on Pharmacokinetics of Meperizumab Injection and NUCALA® in Healthy Male Volunteers Meperizumab injection, NUCALA® - Granulomatosis With Polyangiitis, Hemophagocytic Syndrome | Early Phase 1 | Unknown | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 88 | 2022-06-01 | 2022-04-29 |
| A Clinical Study of CD19/BCMA CAR-T Cells in the Treatment of Refractory POEMS Syndrome, Amyloidosis, Autoimmune Hemolytic Anemia, and Vasculitis CD19/BCMA CAR T-cells - POEMS Syndrome, Amyloidosis | Early Phase 1 | Unknown | Zhejiang University | 75 | 2021-10-08 | 2022-03-03 |
| Sensitivity and Specificity of Color Doppler Directed Temporal Artery Biopsy as Compared to Standard Random Biopsy in the Diagnosis of Temporal Arteritis biopsy of temporal artery - Temporal Arteritis, Duplex of Temporal Artery | Early Phase 1 | Unknown | Shaare Zedek Medical Center | 2006-08-01 | 2006-12-06 |
Amyloidosis (1) · Anemia, Hemolytic, Autoimmune (1) · Giant Cell Arteritis (1) · Granulomatosis with Polyangiitis (1) · Lymphohistiocytosis, Hemophagocytic (1) · POEMS Syndrome (1)
Autoimmune Diseases (3) · Cardiovascular Diseases (3) · Immune System Diseases (3) · Vascular Diseases (3) · Hemic and Lymphatic Diseases (2) · Nervous System Diseases (2) · Skin Diseases (2) · Skin Diseases, Vascular (2) · Skin and Connective Tissue Diseases (2) · Abnormalities, Multiple (1) · Anemia (1) · Anemia, Hemolytic (1) · Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Arteritis (1)
mepolizumab (1)
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1) · Shaare Zedek Medical Center (1) · Zhejiang University (1)
China (2) · Israel (1)
David Shemesh, MD (1) · He Huang, PhD (1)